GET THE APP

..

Journal of Diabetic Complications & Medicine

ISSN: 2475-3211

Open Access

Citations Report

Journal of Diabetic Complications & Medicine : Citations & Metrics Report

Articles published in Journal of Diabetic Complications & Medicine have been cited by esteemed scholars and scientists all around the world.

Journal of Diabetic Complications & Medicine has got h-index 6, which means every article in Journal of Diabetic Complications & Medicine has got 6 average citations.

Following are the list of articles that have cited the articles published in Journal of Diabetic Complications & Medicine.

  2024 2023 2022 2021 2020 2019 2018

Total published articles

40 25 32 30 23 3 6

Research, Review articles and Editorials

4 1 2 7 17 0 6

Research communications, Review communications, Editorial communications, Case reports and Commentary

36 24 30 23 6 0 0

Conference proceedings

0 15 51 23 0 15 37

Citations received as per Google Scholar, other indexing platforms and portals

127 89 16 18 13 13 7
Journal total citations count 102
Journal impact factor 2.05
Journal 5 years impact factor 0.74
Journal cite score 2.71
Journal h-index 6
Journal h-index since 2019 4
Important citations

Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes.

Diabetes Mellitus:? Pathogenesis and Treatment Strategies

DIABETES AND HERBAL MEDICINES

PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesity

Meta-analysis: Metformin Treatment in Persons at Risk for Diabetes Mellitus

Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form

Translating Lifestyle Intervention to Practice in Obese Patients With Type 2 Diabetes Improving Control with Activity and Nutrition (ICAN) study

Painful sensory polyneuropathy associated with impaired glucose tolerance

Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease

Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level

Archimedes A trial-validated model of diabetes

Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During Hypoglycemia

Effect of Orlistat in Overweight and Obese Patients With Type 2 Diabetes Treated With Metformin

Clinical Efficacy of Orlistat Therapy in Overweight and Obese Patients With Insulin-Treated Type 2 Diabetes

Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice

Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients

Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects

High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans A Potential Role for Regulation of Specific Bcl Family Genes Toward an Apoptotic Cell Death Program

Increased Uncoupling Protein-2 Levels in ?-cells Are Associated With Impaired Glucose-Stimulated Insulin Secretion Mechanism of Action

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study

arrow_upward arrow_upward